Results 11 to 20 of about 1,738 (65)
Journal of Diabetes, Volume 15, Issue 4, Page 289-298, April 2023., 2023 Highlights This long‐term longitudinal study demonstrates the association between alcohol consumption and health outcomes in patients with abnormal glucose metabolism including type 2 diabetes mellitus and prediabetes. Occasional drinking (less than once a week) reduces the risk of all‐cause mortality, while heavy alcohol consumption (≥30 g/day for men
Mengzhao Cui +7 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2019 尿微量白蛋白（MAU）反映了肾脏血管内皮细胞功能,早期可评价肾脏功能,尿白蛋白水平增加也会增加全因死亡和心血管死亡的风险,因此,尿微量白蛋白不仅是肾衰的预测因子,也是独立的全因死亡和心脑血管死亡率的预测因子[1]。MAU与器官损伤相关,与多种疾病更是密切相关,如高血压、糖尿病和代谢综合征等,因此,在一定程度上解释了MAU可增加心血管疾病的患病风险并影响其临床预后 ...
李肖楠, 孙威, 王越晖
doaj
Zhongguo cuzhong zazhi代谢性脑血管病是一个新近提出的概念，指由传统代谢危险因素和残余代谢危险因素引起的脑血管损害，通过干预代谢危险因素可有效改善其预后的一种临床综合征。代谢途径并非独立存在，脑、心脏、肝脏、肾脏和肠道等多个器官的各种代谢途径相互影响、共同作用、交织成网，构成了人体的代谢网络，而代谢网络的异常导致了代谢性脑血管病的发生。同时，代谢危险因素的存在可同时造成多个靶器官损害，且神经系统与心血管系统、内分泌系统、消化系统等可通过多种病理生理过程相互影响。因此 ...
许杰, 王拥军 XU Jie, WANG Yongjun
doaj +1 more source
Zhongguo shiyan zhenduanxue, 2019 缺血性脑卒中是人类有高致死率、高致残率、高复发率的疾病,糖尿病则是一种以高血糖和葡萄糖不耐受为主要特征的代谢疾病,易并发血管、神经、视网膜、肾脏、心脏等多个系统与脏器的慢性损害以及功能障碍症状,临床实践证明,糖尿病已经成为脑梗死患者发病的独立危险因素[1],糖尿病患者并发脑梗死几率明显高于非糖尿病患者,一方面,糖尿病患者脑梗死的风险是非糖尿病患者的1.5-3倍;另一方面,脑梗死患者的糖尿病患病率在10%-20%
张晓丽, 崔焜焱, 姚建华
doaj
Zhongguo shiyan zhenduanxue, 2017 随着社会经济的发展和人们生活方式、饮食结构的改变,超重和肥胖已经成为全球重要的公共健康问题[1-2]。根据WHO的诊断标准[3],约有17%的亚洲人为肥胖。肥胖也与许多慢性疾病息息相关[2-4],是公认的糖尿病等代谢相关疾病和心脑血管疾病等重要危险因素,并可增加死亡风险。目前临床上多用体重指数（Body Mass Index,BMI）、腰围（Waist Circumferance,WC ...
金梦, 金立民, 王多友, 陈适
doaj
[Correlation between cardiovascular health score based on eight life factors and prognosis of ischemic stroke and mediating effect of clinical test indicators: a multicenter prospective cohort study]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoLiang X +8 more
europepmc +1 more source
[Plasma metabolites mediates the causal effect of inflammatory proteins on Alzheimer's disease: a Mendelian randomization study]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoChen M, Huang R, Yang Z.
europepmc +1 more source
[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiRao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
[Clinical research progress in 2025 for hepatic fibrosis, cirrhosis, and portal hypertension]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHan YF, Xu XY.
europepmc +1 more source
[Oral homeostasis imbalance under hypoxia]. [PDF]
Hua Xi Kou Qiang Yi Xue Za ZhiXu Y, Wang S, Zhou J.
europepmc +1 more source